AI-powered nano formulation: revolutionizing drug development and delivery

Abstract

This study examines the revolutionary potential of AI-driven nanotechnology in redefining drug development and delivery systems. Nano formulations offer numerous advantages over traditional methods, including enhanced drug efficacy, targeted delivery, and reduced side effects. However, limitations like batch-to-batch variability hinder their widespread adoption. AI integration addresses these challenges by enabling data-driven design optimization, predictive modelling, and streamlined quality control in nano-formulation manufacturing processes. AI-powered algorithms can utilize large datasets to develop nanoparticles tailored for targeted drug delivery, and to foresee their interactions with biological entities. This approach can significantly accelerate the development of innovative nanomedicines and improve their clinical translation. Despite promising advancements, technical challenges related to data quality and regulatory hurdles remain. Additionally, ethical considerations regarding privacy, bias, and transparency in AI algorithms need to be addressed. The future of AI-driven nanomedicine holds exciting possibilities, such as autonomous nano formulation design and smart nanoparticles with controlled drug release. Further research focusing on advanced AI models, improved data integration, and interdisciplinary collaboration is crucial to fully realize the potential of this technology and bring us closer to achieving personalized and effective treatments.